x
Volume 47 Issue 3
Mar.  2024
Turn off MathJax
Article Contents
HOU Pengfei, HAN Xue, WANG Hong, JU Chao, ZHANG Fulan, HAO Lu. Application value of amide proton transfer combined with quantitative susceptibility mapping in the diagnosis of Parkinson's disease[J]. Journal of Molecular Imaging, 2024, 47(3): 225-230. doi: 10.12122/j.issn.1674-4500.2024.03.01
Citation: HOU Pengfei, HAN Xue, WANG Hong, JU Chao, ZHANG Fulan, HAO Lu. Application value of amide proton transfer combined with quantitative susceptibility mapping in the diagnosis of Parkinson's disease[J]. Journal of Molecular Imaging, 2024, 47(3): 225-230. doi: 10.12122/j.issn.1674-4500.2024.03.01

Application value of amide proton transfer combined with quantitative susceptibility mapping in the diagnosis of Parkinson's disease

doi: 10.12122/j.issn.1674-4500.2024.03.01
Funds:

Open Project of State Key Laboratory SKL-HIDCA-2022-NKX7

  • Received Date: 2023-12-26
    Available Online: 2024-04-17
  • Publish Date: 2024-03-20
  •   Objective  To explore the clinical application value of amide proton transfer (APT) and quantitative susceptibility mapping (QSM) for the diagnosis of Parkinson's disease (PD).  Methods  A total of 38 patients who were diagnosed with PD in the Second Affiliated Hospital of Xinjiang Medical University from June 2022 to June 2023 were included as the PD group, and 22 matched healthy control volunteers were recruited during the same period. QSM and APT images of all subjects were collected. The magnetic susceptibility value (MSV) and magnetization transfer asymmetry (MTRasym) of the substantia nigra region were obtained. The prediction probability of the combined diagnosis of two kinds of parameters was modeled by Logistics regression, and the diagnostic efficiency of the single imaging technology and the combined diagnosis of two kinds of imaging technology was compared by the ROC curve.  Results  Compared with the healthy control group, the average MSV value of substantia nigra in the PD group was significantly higher, while the average MTRasym value of substantia nigra in the PD group was significantly lower (P < 0.001). MSV value of substantia nigra on the more heavily affected side was higher than that on the less lightly affected side(P < 0.001), and MTRasym value of substantia nigra on the more heavily affected side was lower than that on the less lightly affected side (P < 0.05). Using the average values of bilateral substantia nigra, the area under the ROC curve of APT, QSM and QSM combined with APT were 0.812, 0.873, 0.897. While using the values of the more affected side, the area under the ROC curve of QSM combined with APT was 0.928.  Conclusion  Both QSM and APT have high diagnostic efficacy for PD. QSM combined with APT has higher diagnostic efficacy for PD compared with QSM or APT alone and can provide an imaging basis for accurate diagnosis of PD.

     

  • loading
  • [1]
    Zheng ZL, Zhu ZY, Zhou C, et al. Burden of parkinson disease in China, 1990-2019: findings from the 2019 global burden of disease study[J]. Neuroepidemiology, 2023, 57(1): 51-64. doi: 10.1159/000527372
    [2]
    Qi SG, Yin P, Wang LH, et al. Prevalence of Parkinson's disease: a community- based study in China[J]. Mov Disord, 2021, 36(12): 2940-4. doi: 10.1002/mds.28762
    [3]
    Armstrong MJ, Okun MS. Diagnosis and treatment of parkinson disease: a review[J]. JAMA, 2020, 323(6): 548-60. doi: 10.1001/jama.2019.22360
    [4]
    Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of Parkinson's disease[J]. Lancet Neurol, 2021, 20(5): 385-97. doi: 10.1016/S1474-4422(21)00030-2
    [5]
    Li G, Ma JF, Cui SS, et al. Parkinson's disease in China: a forty-year growing track of bedside work[J]. Transl Neurodegener, 2019, 8: 22. doi: 10.1186/s40035-019-0162-z
    [6]
    Harada T, Kudo K, Fujima N, et al. Quantitative susceptibility mapping: basic methods and clinical applications[J]. Radiographics, 2022, 42(4): 1161-76. doi: 10.1148/rg.210054
    [7]
    Mahoney-Sánchez L, Bouchaoui H, Ayton S, et al. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease[J]. Prog Neurobiol, 2021, 196: 101890. doi: 10.1016/j.pneurobio.2020.101890
    [8]
    Shi LQ, Huang C, Luo QH, et al. The association of iron and the pathologies of Parkinson's diseases in MPTP/MPP +- induced neuronal degeneration in non- human Primates and in cell culture [J]. Front Aging Neurosci, 2019, 11: 215. doi: 10.3389/fnagi.2019.00215
    [9]
    Ward RJ, Zucca FA, Duyn JH, et al. The role of iron in brain ageing and neurodegenerative disorders[J]. Lancet Neurol, 2014, 13(10): 1045-60. doi: 10.1016/S1474-4422(14)70117-6
    [10]
    Dexter DT, Wells FR, Lees AJ, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease[J]. J Neurochem, 1989, 52(6): 1830-6. doi: 10.1111/j.1471-4159.1989.tb07264.x
    [11]
    米日班·买买提库尔班, 张树贤, 马景旭, 等. 酰胺质子转移磁共振成像在帕金森病中的研究进展[J]. 磁共振成像, 2023, 14(6): 94-8. https://www.cnki.com.cn/Article/CJFDTOTAL-CGZC202306016.htm
    [12]
    Reichenbach JR, Schweser F, Serres B, et al. Quantitative susceptibility mapping: concepts and applications[J]. Clin Neuroradiol, 2015, 25(2): 225-30.
    [13]
    王钧豪, 苏一飞, 成睿, 等. 酰胺质子转移成像在脑胶质瘤诊断及分子分型预测中的研究进展[J]. 分子影像学杂志, 2023, 46(4): 765-8. doi: 10.12122/j.issn.1674-4500.2023.04.33
    [14]
    Koike H, Morikawa M, Ishimaru H, et al. Amide proton transfer-chemical exchange saturation transfer imaging of intracranial brain tumors and tumor- like lesions: our experience and a review[J]. Diagnostics, 2023, 13(5): 914. doi: 10.3390/diagnostics13050914
    [15]
    Zhou JY, Heo HY, Knutsson L, et al. APT- weighted MRI: techniques, current neuro applications, and challenging issues[J]. J Magn Reson Imaging, 2019, 50(2): 347-64. doi: 10.1002/jmri.26645
    [16]
    Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease[J]. Mov Disord, 2015, 30(12): 1591-601. doi: 10.1002/mds.26424
    [17]
    陈永平, 商慧芳. 2016中国帕金森病诊断标准解读[J]. 中国实用内科杂志, 2017, 37(2): 124-6. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201702010.htm
    [18]
    An HD, Zeng XY, Niu TF, et al. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping[J]. J Neurol Sci, 2018, 386: 46-52. doi: 10.1016/j.jns.2018.01.008
    [19]
    Li KR, Avecillas-Chasin J, Nguyen TD, et al. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease[J]. J Neuroimaging, 2022, 32(2): 363-71. doi: 10.1111/jon.12957
    [20]
    Zhao QY, Tao YQ, Zhao K, et al. Structural insights of Fe3+ induced α-synuclein fibrillation in Parkinson's disease[J]. J Mol Biol, 2023, 435(1): 167680. doi: 10.1016/j.jmb.2022.167680
    [21]
    Herman S, Djaldetti R, Mollenhauer B, et al. CSF- derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology[J]. Brain, 2023, 146(1): 209-24. doi: 10.1093/brain/awac261
    [22]
    Zhang JQ, Zhang YL, Wang J, et al. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study[J]. Brain Res, 2010, 1330: 124-30. doi: 10.1016/j.brainres.2010.03.036
    [23]
    Zhang Y, Wu IW, Buckley S, et al. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease[J]. Mov Disord, 2015, 30 (9): 1229-36. doi: 10.1002/mds.26251
    [24]
    Baumann CR, Held U, Valko PO, et al. Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression[J]. Mov Disord, 2014, 29(2): 207-13. doi: 10.1002/mds.25650
    [25]
    Li CM, Chen M, Zhao XN, et al. Chemical exchange saturation transfer MRI signal loss of the substantia nigra as an imaging biomarker to evaluate the diagnosis and severity of Parkinson's disease[J]. Front Neurosci, 2017, 11: 489. doi: 10.3389/fnins.2017.00489
    [26]
    Li CM, Wang R, Chen HB, et al. Chemical exchange saturation transfer MR imaging is superior to diffusion-tensor imaging in the diagnosis and severity evaluation of Parkinson's disease: a study on substantia nigra and Striatum[J]. Front Aging Neurosci, 2015, 7: 198.
    [27]
    Zhao YJ, Wee HL, Chan YH, et al. Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times[J]. Mov Disord, 2010, 25(6): 710-6. doi: 10.1002/mds.22875
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Article Metrics

    Article views (31) PDF downloads(10) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return